These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus. O'Flaherty S; Klaenhammer TR Appl Environ Microbiol; 2016 Oct; 82(20):6091-6101. PubMed ID: 27496774 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant. Park YS; Lee JH; Hung CF; Wu TC; Kim TW Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494 [TBL] [Abstract][Full Text] [Related]
9. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities. Sloat BR; Cui Z Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616 [TBL] [Abstract][Full Text] [Related]
10. Colonic immune stimulation by targeted oral vaccine. Kathania M; Zadeh M; Lightfoot YL; Roman RM; Sahay B; Abbott JR; Mohamadzadeh M PLoS One; 2013; 8(1):e55143. PubMed ID: 23383086 [TBL] [Abstract][Full Text] [Related]
11. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model. Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543 [TBL] [Abstract][Full Text] [Related]
13. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model. Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624 [TBL] [Abstract][Full Text] [Related]
14. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043 [TBL] [Abstract][Full Text] [Related]
15. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Welkos S; Little S; Friedlander A; Fritz D; Fellows P Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699 [TBL] [Abstract][Full Text] [Related]
16. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice. Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985 [TBL] [Abstract][Full Text] [Related]
18. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. Gorantala J; Grover S; Rahi A; Chaudhary P; Rajwanshi R; Sarin NB; Bhatnagar R J Biotechnol; 2014 Apr; 176():1-10. PubMed ID: 24548460 [TBL] [Abstract][Full Text] [Related]
19. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination. Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452 [TBL] [Abstract][Full Text] [Related]
20. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model. Varshney A; Kumar M; Nagar DP; Pal V; Goel AK Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]